The Patent Finder

Jiangzhong Pharmaceutical Co., Ltd.

6 patents currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Dec 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jul 21, 2027
    The maintenance fee for Traditional Chinese medicine combination for regulating immune function and preparation method therefor (US 10,537,600) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 6 of 6

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,986,750Use of a traditional chinese medicine composition for manufacturing a health food or medicament for preventing and alleviating physical fatigue
In force
 · USPTO record
In forceUSPTO record
US 9,861,671Composition for preventing and treating aids and preparation method thereof
In force
 · USPTO record
In forceUSPTO record
US 9,775,868Traditional Chinese medicine combination for regulating immune function and preparation method therefor
In force
 · USPTO record
In forceUSPTO record
US 10,537,600Traditional Chinese medicine combination for regulating immune function and preparation method therefor
In force
 · USPTO record
In forceUSPTO record
US 9,744,203Application of composition in preparing health care product or medicine for preventing and treating leukopenia caused by radiotherapy and chemotherapy
In force
 · USPTO record
In forceUSPTO record
US 10,086,030Use of composition in preparing health care products or medicines for preventing and treating allergic diseases
In force
 · USPTO record
In forceUSPTO record

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited